We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Batavia Bioservices and UvA Holding Announce STEP™ Technology Exclusive License
News

Batavia Bioservices and UvA Holding Announce STEP™ Technology Exclusive License

Batavia Bioservices and UvA Holding Announce STEP™ Technology Exclusive License
News

Batavia Bioservices and UvA Holding Announce STEP™ Technology Exclusive License

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Batavia Bioservices and UvA Holding Announce STEP™ Technology Exclusive License"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Under the agreement, Batavia Bioservices has been granted the exclusive license to the STEP™ technology, a revolutionary, plasmid-based system that significantly reduces the time required to develop recombinant protein-producing mammalian cell lines while increasing protein production more than 10-fold.

Menzo Havenga (CEO Batavia Bioservices) commented: “We are very pleased that UvA Holding has selected Batavia Bioservices as its marketing partner for STEP™ technology since we firmly believe that this technology will significantly reduce manufacturing costs."

Chris Yallop (COO Batavia Bioservices) added: “STEP™ technology also allows the development of so-called rare diseases biopharmaceutical products, which have always been considered too expensive to develop."

Piet Scholten (Director UvA Holding BV) concluded: “With their in-depth know how in biopharm manufacturing, vast network, and presence in both Europe and USA, Batavia Bioservices provided the ideal landing platform for marketing our technology and we look forward to a fruitful relationship!”

Financial details of the exclusive license agreement were not disclosed.

Advertisement